NEW YORK ( TheStreet) -- ImClone founder Samuel Waksal is raising money, hoping to launch a biopharmaceutical start-up. But it wasn't so long ago that the biotech entrepreneur was serving seven years behind bars for a series of white collar crimes that also enmeshed friend and domestic doyenne Martha Stewart.A quick recap: After receiving a tip in December 2001 that the U.S. Food and Drug Administration would reject the application for Erbitux, a colon cancer drug, Waksal tried to sell 80,000 of the company's shares. The day before the FDA's rejection, Waksal's family, close friends, and other big ImClone shareholders -- including Stewart -- sold millions worth of stock. The stock then started to tank, falling into the teens after its December high of around $60.
ImClone Scandal: A Timeline
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.